A detailed history of Fort Pitt Capital Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fort Pitt Capital Group, LLC holds 624,947 shares of MRK stock, worth $61.3 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares
624,947
Previous 577,332 8.25%
Holding current value
$61.3 Million
Previous $71.5 Million 0.71%
% of portfolio
2.01%
Previous 2.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$111.15 - $128.97 $5.29 Million - $6.14 Million
47,615 Added 8.25%
624,947 $71 Million
Q2 2024

Jul 26, 2024

BUY
$123.8 - $132.96 $739,952 - $794,701
5,977 Added 1.05%
577,332 $71.5 Million
Q1 2024

Apr 11, 2024

BUY
$113.24 - $131.95 $1.26 Million - $1.46 Million
11,093 Added 1.98%
571,355 $75.4 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $3.27 Million - $3.56 Million
32,660 Added 6.19%
560,262 $61.1 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $2.23 Million - $2.47 Million
21,645 Added 4.28%
527,602 $54.3 Million
Q2 2023

Jul 28, 2023

BUY
$108.61 - $118.38 $1.76 Million - $1.92 Million
16,199 Added 3.31%
505,957 $58.4 Million
Q1 2023

May 16, 2023

BUY
$102.94 - $114.86 $2.17 Million - $2.43 Million
21,120 Added 4.51%
489,758 $52.1 Million
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $381,063 - $488,575
4,358 Added 0.94%
468,638 $52 Million
Q3 2022

Nov 08, 2022

BUY
$84.53 - $94.96 $4.05 Million - $4.55 Million
47,871 Added 11.5%
464,280 $40 Million
Q2 2022

Jul 20, 2022

BUY
$83.49 - $94.64 $22 Million - $24.9 Million
263,237 Added 171.86%
416,409 $38 Million
Q1 2022

May 03, 2022

BUY
$73.51 - $82.4 $1.33 Million - $1.49 Million
18,111 Added 13.41%
153,172 $12.6 Million
Q4 2021

Feb 02, 2022

BUY
$72.28 - $90.54 $1.13 Million - $1.42 Million
15,686 Added 13.14%
135,061 $10.4 Million
Q3 2021

Nov 05, 2021

BUY
$71.68 - $78.83 $756,797 - $832,287
10,558 Added 9.7%
119,375 $8.97 Million
Q2 2021

Jul 29, 2021

BUY
$70.31 - $77.77 $625,266 - $691,608
8,893 Added 8.9%
108,817 $8.46 Million
Q1 2021

Apr 16, 2021

BUY
$68.86 - $81.11 $819,434 - $965,209
11,900 Added 13.52%
99,924 $7.7 Million
Q4 2020

Feb 24, 2021

BUY
$71.77 - $79.65 $6.31 Million - $7 Million
87,936 Added 99927.27%
88,024 $7.2 Million
Q4 2020

Feb 23, 2021

SELL
$71.77 - $79.65 $6.21 Million - $6.89 Million
-86,512 Reduced 99.9%
88 $7.2 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $32,418 - $36,746
-443 Reduced 0.51%
86,600 $7.18 Million
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $62,251 - $70,834
884 Added 1.03%
87,043 $6.73 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $2.94 Million - $4.07 Million
46,330 Added 116.32%
86,159 $6.63 Million
Q4 2019

Feb 18, 2020

SELL
$77.58 - $87.54 $284,330 - $320,834
-3,665 Reduced 8.43%
39,829 $3.62 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $1.34 Million - $1.46 Million
17,588 Added 67.89%
43,494 $3.66 Million
Q2 2019

Aug 09, 2019

SELL
$69.84 - $81.59 $177,114 - $206,912
-2,536 Reduced 8.92%
25,906 $2.17 Million
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $231,631 - $264,189
-3,329 Reduced 10.48%
28,442 $2.37 Million
Q4 2018

Feb 06, 2019

BUY
$65.24 - $75.71 $243,279 - $282,322
3,729 Added 13.3%
31,771 $2.43 Million
Q3 2018

Nov 06, 2018

SELL
$57.69 - $67.84 $19,095 - $22,455
-331 Reduced 1.17%
28,042 $1.99 Million
Q2 2018

Aug 09, 2018

BUY
$50.83 - $59.72 $26,431 - $31,054
520 Added 1.87%
28,373 $1.72 Million
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $124,342 - $144,521
2,440 Added 9.6%
27,853 $1.52 Million
Q4 2017

Feb 02, 2018

SELL
$51.62 - $61.64 $7,743 - $9,246
-150 Reduced 0.59%
25,413 $1.43 Million
Q3 2017

Oct 26, 2017

BUY
$58.67 - $63.13 $205,462 - $221,081
3,502 Added 15.87%
25,563 $1.64 Million
Q2 2017

Aug 17, 2017

BUY
N/A
22,061
22,061 $1.41 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fort Pitt Capital Group, LLC Portfolio

Follow Fort Pitt Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Pitt Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Pitt Capital Group, LLC with notifications on news.